Summary- On January 18, 2024, the Center for Medicare and Medicaid Innovation (CMMI) at the Centers for Medicare and Medicaid Services (CMS) announced Innovations in.
11. COVID-19 and Life Sciences</strong>, the US government has used a wide variety of
public procurement and funding strategies for needed medical
countermeasures during the pandemic.
This Week in Washington: Congress passes six appropriations bills including skinny health package; House Ways and Means Committee reports bill to block CMS nursing home minimum staffing.
On January 30, the Centers for Medicare & Medicaid Services' (CMS') Innovation Center announced that sickle cell disease (SCD) will be the first focus of the Cell and Gene Therapy (CGT).
CMS in February 2023 announced 3 new models for testing by the Center for Medicare & Medicaid Innovation all of which “aim to lower the cost of drugs, promote accessibility to life-changing drug therapies, and improve quality of care.”